Primary Liver Cancer: 2025 China Diagnosis and Treatment Guideline
China's 2025 primary liver cancer guideline (focused on hepatocellular carcinoma) refines early screening with ultrasound plus AFP, stresses MDT-based staging, and standardizes surgery, ablation, TACE, systemic therapy, and liver transplantation pathways.
Updated 2025-04-10 · Reviewed for clinical accuracy
Scope and burden
Screening and diagnosis
Staging and MDT
Treatment options
For patients
In short
“Primary Liver Cancer: 2025 China Diagnosis and Treatment Guideline” is part of iMedCompanion’s plain-language library for international patients travelling to China for care. It explains what usually happens, what to prepare, and where to find related specialists and hospitals.
Key facts
Published in English
Reading time shown on every guide
Links to related specialists and hospitals
Reviewed for clinical accuracy
Frequently asked questions
Is this guide medical advice?
No. It explains what usually happens so you can ask better questions; decisions are made with your own specialist.
Can I get the guide in Chinese?
The guides are published in English; interpretation and translation are arranged as a separate service.
How do I find a specialist for this?
Each guide links to related specialists and hospitals, or you can send an enquiry and a medical advisor will match you.
Polycythemia vera is a blood disorder causing excess red cells and clot risk, managed by phlebotomy, aspirin, and cytoreductive therapy…
4 min readUpdated 2025-01-01
We use strictly necessary cookies to run this website. Optional analytics cookies help us
understand how the site is used, and load only if you agree. See our
Cookie Policy.